Skip to main content
OpenTrials
Completed

NCT Number: NCT02943421

Transverse B-Lynch in Management of Placenta Accreta

Placenta accreta is considered a severe pregnancy complication that may be associated with massive and potentially life-threatening intrapartum and postpartum hemorrhage. Life-threatening bleeding is the most common complication to be associated with this condition; the average blood loss at time of delivery is reported to be 3000-5500 mL, which leads to significant postoperative morbidity and death.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Decrease Maternal Morbidity

Sex eligibility

Female

Study type

Observational

Primary location

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All pregnant women with placenta previa as diagnosed by ultrasound with suspicion of abnormal placentation by Doppler us, confirmed intraoperatively undergoing either emergent or elective cesarean

Exclusion criteria

  • Patients who will be managed by hysterectomy
  • Patients who will be managed by conservative leaving the placenta in-situ

Treatment and study plan

Transverse B-Lynch suture

Procedure

Primary outcomes

  1. Estimated intraoperative blood loss

    Time frame: 30 min

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Evaluation of the Efficacy of Transverse B-Lynch in Management of Placenta Accreta

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Oct 24, 2016
Registry last updated
Jun 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.